Last reviewed · How we verify
Steboronine (borofalan (10B))
Steboronine (generic name: borofalan (10B)) is a drug developed by Stella Pharma. It is currently FDA-approved for Neoplasm of head and neck.
Borofalan (Steboronine), marketed by Stella Pharma, is a targeted radiotherapeutic agent indicated for neoplasms of the head and neck, with a key composition patent expiring in 2028. Its unique mechanism of delivering a radioactive isotope of boron directly to cancer cells provides a precise and potent treatment option, distinguishing it from off-patent competitors like melphalan. The primary risk is the limited revenue data and the presence of generic alternatives, which may impact market share and profitability.
At a glance
| Generic name | borofalan (10B) |
|---|---|
| Sponsor | Stella Pharma |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Approved indications
- Neoplasm of head and neck
Common side effects
Key clinical trials
- A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Malignant Brain Tumors (PHASE1,PHASE2)
- Dose Optimized BNCT for Head and Neck Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Steboronine CI brief — competitive landscape report
- Steboronine updates RSS · CI watch RSS
- Stella Pharma portfolio CI
Frequently asked questions about Steboronine
What is Steboronine?
What is Steboronine used for?
Who makes Steboronine?
What is the generic name of Steboronine?
What development phase is Steboronine in?
Related
- Manufacturer: Stella Pharma — full pipeline
- Therapeutic area: All drugs in Oncology
- Indication: Drugs for Neoplasm of head and neck
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing